ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Medexus Pharmaceuticals Inc

Medexus Pharmaceuticals Inc (MDP)

2,45
0,32
(15,02%)
Geschlossen 23 November 10:12PM

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
2,45
Gebot
2,28
Fragen
2,45
Volumen
46.306
2,08 Tagesbereich 2,45
1,44 52-Wochen-Bereich 3,16
Marktkapitalisierung
Handelsende
2,13
Handelsbeginn
2,13
Letzte Trade
400
@
2.45
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
28.111
Ausgegebene Aktien
24.458.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-281,61
Gewinn pro Aktie (EPS)
-0,01
Erlöse
113,05M
Nettogewinn
-214k

Über Medexus Pharmaceuticals Inc

Sektor
Pharmaceutical Preparations
Branche
Blank Checks
Website
Hauptsitz
Bolton, Gbr
Gegründet
2013
Medexus Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the Toronto Börse with ticker MDP. The last closing price for Medexus Pharmaceuticals was $2,13. Over the last year, Medexus Pharmaceuticals shares have traded in a share price range of $ 1,44 to $ 3,16.

Medexus Pharmaceuticals currently has 24.458.000 shares in issue. The market capitalisation of Medexus Pharmaceuticals is $52,10 million. Medexus Pharmaceuticals has a price to earnings ratio (PE ratio) of -281.61.

MDP Neueste Nachrichten

Medexus Pharmaceuticals Announces C$10 Million Bought-Deal Public Offering of Units

TORONTO and CHICAGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. ("Medexus" or the "Company") (TSX: MDP) (OTCQX: MEDXF), is pleased to announce that it has entered into an...

Medexus to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference

TORONTO and CHICAGO, April 18, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF) is pleased to announce that company management will be participating in the 2023 Bloom...

Medexus Expects Record Revenue for Fiscal Year 2023 and Provides Business Update

TORONTO and CHICAGO, April 11, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF) is pleased to announce preliminary revenue estimates for the company’s fourth fiscal...

Medexus Announces New License Deal for Topical Terbinafine

TORONTO and CHICAGO, March 22, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF) is pleased to announce that the company has secured Canadian rights to commercialize...

Medexus Announces US$58.5 million in New Credit Facilities

TORONTO and CHICAGO, March 08, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (TSX: MDP; TSX: MDP.DB; OTCQX: MEDXF) today entered into a new senior secured credit agreement agented by BMO. The...

Medexus to Participate in 35th Annual Roth Conference

TORONTO and CHICAGO, March 06, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF) is pleased to announce that company management will be participating in the 35th Annual...

Medexus Announces Another Record Quarter with Fiscal Q3 2023 Revenue of US$28.7 Million, a 35% Increase Over Fiscal Q3 2022

Results reflect growth across all leading prescription products, demonstrating continued track record of strong overall performance Management to host conference call at 8:00 AM Eastern Time on...

Medexus Welcomes Two New Board Members

Harmony P. Garges MD MPH and Menassie Taddese MBA appointed to Medexus’s board of directors Appointments bolster Medexus board’s medical and financial expertise, particularly in the United States...

Medexus Secures Public Reimbursement for Cuvposa® in Quebec

TORONTO and CHICAGO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (Medexus) (TSX: MDP) (OTCQX: MEDXF) wishes to inform investors that the company has reached an agreement with the...

Medexus Schedules Third Fiscal Quarter 2023 Conference Call

TORONTO and CHICAGO, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (Medexus) (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Thursday...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.4421.89054726372.012.452.01492612.14234516CS
4-0.14-5.405405405412.592.61.72400562.14164166CS
120.031.239669421492.422.751.72281112.35035051CS
260.8351.23456790121.622.751.5337752.13955855CS
520.8856.0509554141.573.161.44451521.98463371CS
156-0.63-20.45454545453.083.530.88369402.05718395CS
260-4.93-66.80216802177.387.90.88387032.39589377CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
AABAberdeen International Inc
$ 0,065
(18,18%)
226,54k
MDPMedexus Pharmaceuticals Inc
$ 2,45
(15,02%)
46,31k
NCFNorthcliff Resources Ltd
$ 0,04
(14,29%)
5k
SAMStarcore International Mines Ltd
$ 0,16
(14,29%)
200k
GECGlobal Education Communities Corp
$ 0,225
(12,50%)
60k
BNGBengal Energy Ltd
$ 0,005
(-50,00%)
20k
RTGRTG Mining Inc
$ 0,03
(-25,00%)
13k
SMCSulliden Mining Capital Inc
$ 0,015
(-25,00%)
200k
APSAptose Biosciences Inc
$ 0,27
(-20,59%)
346,55k
FLNTFlint Corporation
$ 0,025
(-16,67%)
28k
SUSuncor Energy Inc
$ 58,04
(0,94%)
14,14M
MFCManulife Financial Corporation
$ 45,42
(-0,53%)
9,73M
SLFSun Life Financial Inc
$ 85,54
(-0,23%)
6,19M
BITFBitfarms Ltd
$ 2,96
(3,14%)
6,17M
CNQCanadian Natural Resources Ltd
$ 48,70
(0,83%)
4,91M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen